Weerachai Chaijamorn

6PUBLICATIONS
7CO-AUTHORS
PharmacogenomicsCancer therapy (excl. chemotherapy and radiation therapy)Toxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Mar 30, 2026
Meropenem Dosing Recommendations in Critically Ill Patients Receiving Prolonged Intermittent Renal Replacement Therapy.

Jirapat Vamananda, Weerachai Chaijamorn, Taniya Charoensareerat

|Apr 26, 2024
Pharmacokinetics of intravenous piperacillin/tazobactam among patients with peritoneal dialysis-associated peritonitis.

Taweesak Maneerot, Suwikran Wongpraphairot, Aroonrut Lucksiri

|Nov 10, 2023
Lacosamide dosing in patients receiving continuous renal replacement therapy.

Weerachai Chaijamorn, Sathian Phunpon, Thanompong Sathienluckana

|Jul 10, 2023
Recommendations of Gentamicin Dose Based on Different Pharmacokinetic/Pharmacodynamic Targets for Intensive Care Adult Patients: A Redefining Approach.

Mohammad Yaseen Abbasi, Weerachai Chaijamorn, Kamonthip Wiwattanawongsa

|Feb 22, 2023
Piperacillin-tazobactam dosing in anuric acute kidney injury patients receiving continuous renal replacement therapy.

Dhakrit Rungkitwattanakul, Taniya Charoensareerat, Ekanong Chaichoke

|Sep 18, 2018
Cefepime dosing regimens in critically ill patients receiving continuous renal replacement therapy: a Monte Carlo simulation study.

Weerachai Chaijamorn, Taniya Charoensareerat, Nattachai Srisawat

Pageof 1